Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa

V-antigen homologs in pathogenic gram-negative bacteria

(2014) Teiji Sawa et al.   MICROBIOLOGY AND IMMUNOLOGY

Hospital-acquired pneumonia and ventilator-associated pneumonia

(2013) François Barbier et al.   CURRENT OPINION IN PULMONARY MEDICINE

Anti-PcrV antibody in cystic fibrosis: A novel approach targetingPseudomonas aeruginosaairway infection

(2013) Carlos E. Milla et al.   PEDIATRIC PULMONOLOGY

Type III Secretion of ExoU Is Critical during Early Pseudomonas aeruginosa Pneumonia

(2013) H. A. Howell et al.   mBio

Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa

(2012) Bruno François et al.   CRITICAL CARE MEDICINE

Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy

(2012) Matteo Bassetti et al.   Expert Review of Anti-Infective Therapy

Differentiation in Quinolone Resistance by Virulence Genotype in Pseudomonas aeruginosa

(2012) Melissa Agnello et al.   PLoS One

Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens

(2012) Philip E Grgurich et al.   Expert Review of Respiratory Medicine

Clinical outcomes of type III Pseudomonas aeruginosa bacteremia*

(2011) Ali A. El-Solh et al.   CRITICAL CARE MEDICINE

PcrV antibody–antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice

(2011) Y. Song et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria

(2011) Hiromi Sato et al.   Frontiers in Microbiology

The type III secretion injectisome, a complex nanomachine for intracellular ‘toxin’ delivery

(2010) Guy R. Cornelis   BIOLOGICAL CHEMISTRY

Bacterial Nanomachines: The Flagellum and Type III Injectisome

(2010) M. Erhardt et al.   Cold Spring Harbor Perspectives in Biology

Protective effects of affinity-purified antibody and truncated vaccines againstPseudomonas aeruginosaV-antigen in neutropenic mice

(2009) Kiyoshi Moriyama et al.   MICROBIOLOGY AND IMMUNOLOGY

Biofilms and type III secretion are not mutually exclusive in Pseudomonas aeruginosa

(2009) H. Mikkelsen et al.   MICROBIOLOGY-SGM

The type III secretion system of Pseudomonas aeruginosa: infection by injection

(2009) Alan R. Hauser   NATURE REVIEWS MICROBIOLOGY

Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa

(2008) A. Wong-Beringer et al.   CLINICAL MICROBIOLOGY AND INFECTION

An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity

(2008) M. Baer et al.   INFECTION AND IMMUNITY

Oligomerization of PcrV and LcrV, Protective Antigens ofPseudomonas aeruginosaandYersinia pestis

(2008) Gébus Caroline et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: Prevalence, incidence, risk factors, and outcomes

(2008) Chris M. Parker et al.   JOURNAL OF CRITICAL CARE

The type III secretion system tip complex and translocon

(2008) C. A. Mueller et al.   MOLECULAR MICROBIOLOGY

What's the point of the type III secretion system needle?

(2008) A. J. Blocker et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA